158 related articles for article (PubMed ID: 10897668)
21. [Scoring of disseminated intravascular coagulation (DIC) in intensive care medicine].
Wiedermann CJ; Egi M
Clin Ter; 2008; 159(4):275-81. PubMed ID: 18776987
[TBL] [Abstract][Full Text] [Related]
22. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
Front Immunol; 2020; 11():575890. PubMed ID: 33042158
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
Maruyama I
Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
[TBL] [Abstract][Full Text] [Related]
24. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
Levi M
Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
[No Abstract] [Full Text] [Related]
25. Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.
Wada T; Gando S; Maekaw K; Katabami K; Sageshima H; Hayakawa M; Sawamura A
Crit Care; 2017 Aug; 21(1):219. PubMed ID: 28826407
[TBL] [Abstract][Full Text] [Related]
26. [Immune response induced by surgical trauma].
Hirota M; Ogawa M
Nihon Geka Gakkai Zasshi; 1996 Sep; 97(9):721-5. PubMed ID: 8940682
[TBL] [Abstract][Full Text] [Related]
27. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
28. [Sepsis and multi-organ failure].
Okajima K
Nihon Rinsho; 2003 Mar; 61 Suppl 3():319-24. PubMed ID: 12717991
[No Abstract] [Full Text] [Related]
29. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
30. Cardiopulmonary bypass-induced inflammation: is it important?
Hill GE
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
[TBL] [Abstract][Full Text] [Related]
31. Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells.
Kobayashi M; Shimada K; Ozawa T
J Cell Physiol; 1990 Sep; 144(3):383-90. PubMed ID: 2202741
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
de Jonge E; van der Poll T; Kesecioglu J; Levi M
Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
[TBL] [Abstract][Full Text] [Related]
33. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.
Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Kitamura N; Saitoh D
Crit Care; 2016 Sep; 20():287. PubMed ID: 27629997
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
[TBL] [Abstract][Full Text] [Related]
35. [The role of thrombomodulin in sepsis-associated DIC].
Ito T
Rinsho Ketsueki; 2016 Apr; 57(4):405-11. PubMed ID: 27169442
[TBL] [Abstract][Full Text] [Related]
36. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
37. Protein C inhibitor as an anti-disseminated intravascular coagulation agent--mechanism and modification.
Fujita M; Izutani W; Takahashi K
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):21-7. PubMed ID: 15320803
[TBL] [Abstract][Full Text] [Related]
38. [A new concept of DIC: SIRS-associated coagulopathy].
Koseki K
Rinsho Byori; 2011 Feb; Suppl 147():13-9. PubMed ID: 21761743
[No Abstract] [Full Text] [Related]
39. Antithrombin: anti-inflammatory properties and clinical applications.
Levy JH; Sniecinski RM; Welsby IJ; Levi M
Thromb Haemost; 2016 Apr; 115(4):712-28. PubMed ID: 26676884
[TBL] [Abstract][Full Text] [Related]
40. Actin filament reorganization is a key step in lung inflammation induced by systemic inflammatory response syndrome.
Du L; Zhou J; Zhang J; Yan M; Gong L; Liu X; Chen M; Tao K; Luo N; Liu J
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):597-603. PubMed ID: 22721831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
